Jennison Associates’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Jennison Associates’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-23,728	Closed	-$355K	–	703
2016 Q2	$355K	Buy	+23,728	New	+$305K	﹤0.01%	616
2015 Q3	–	Sell	-17,726	Closed	-$431K	–	796
2015 Q2	$431K	Buy	17,726 +3,842	+28%	+$92K	﹤0.01%	713
2015 Q1	$323K	Buy	+13,884	New	+$367K	﹤0.01%	701
2014 Q2	–	Sell	-14,373	Closed	-$336K	–	781
2014 Q1	$336K	Sell	14,373 -503,151	-97%	-$11M	﹤0.01%	714
2013 Q4	$13.1M	Sell	517,524 -22,299	-4%	-$504K	0.01%	473
2013 Q3	$11M	Sell	539,823 -9,834	-2%	-$219K	0.01%	475
2013 Q2	$11.5M	Buy	+549,657	New	+$9.82M	0.01%	464

Jennison Associates's SGNT Position: Q3 2016 in Review

Jennison Associates sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 23,728 shares — an estimated $355K sold.

Jennison Associates first reported a position in SGNT in Q2 2013 and held it in 7 quarters. The position peaked at $13.1M in Q4 2013. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

Jennison Associates reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
Jennison Associates sold 23,728 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $355K.
Jennison Associates first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 7 quarters.
Jennison Associates's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $13.1M in Q4 2013.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Jennison Associates's 13F filing for Q3 2016, filed 1 Nov 2016.